Photodynamic Therapy with 5-Aminolevulinic Acid Patch for the Treatment of Actinic Keratosis

Photodynamic therapy (PDT) using 5-aminolevulinic acid (5-ALA) is an emerging treatment option in the care of actinic keratosis (AK). A self-adhesive 5-ALA patch was recently developed that allows a precise PDT procedure. Here, we review the current literature and report the findings of our case series that observed the outcomes and safety of 5-ALA patch PDT. Ten patients with a total of 40 AKs were treated with a single session of conventional or daylight PDT using 5-ALA patch at the Department of Dermatology and Venereology, Sapienza University of Rome or at the European Institute of Oncology, Milan, Italy. Complete response was observed in three patients, while partial response was seen in seven patients. Overall tolerability was good or excellent, with local adverse events observed in four patients. This is the first case series reported where the 5-ALA patch was applied using daylight PDT, and its efficacy and tolerability in the treatment of AK were demonstrated. In conclusion, the self-adhesive 5-ALA patch is a convenient application of PDT that provides a well-tolerated and effective treatment option with satisfactory cosmetic outcomes.

[1]  S. Freeman,et al.  Aminolevulinic Acid 20% Solution Combined With Photodynamic Therapy for Treatment of Actinic Keratoses: A Review. , 2021, Journal of drugs in dermatology : JDD.

[2]  Laura Vincent,et al.  Actinic keratosis area and severity index is not correlated with photodynamic therapy procedural pain. , 2020, Photodiagnosis and photodynamic therapy.

[3]  A. Tanew,et al.  5‐Aminolevulinic acid patch (Alacare) photodynamic therapy for actinic cheilitis: data from a prospective 12‐month follow‐up study on 21 patients , 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

[4]  R. Salido-Vallejo,et al.  Combined daylight and conventional photodynamic therapy with 5-aminolaevulinic acid nanoemulsion (BF-200 ALA) for actinic keratosis of the face and scalp: a new and efficient approach , 2019, Archives of Dermatological Research.

[5]  S. Karrer,et al.  European Dermatology Forum guidelines on topical photodynamic therapy 2019 Part 1: treatment delivery and established indications – actinic keratoses, Bowen's disease and basal cell carcinomas , 2019, Journal of the European Academy of Dermatology and Venereology : JEADV.

[6]  S. Dan,et al.  Mechanistic study of PpIX accumulation using the JFCR39 cell panel revealed a role for dynamin 2-mediated exocytosis , 2019, Scientific Reports.

[7]  R. Sroka,et al.  Conventional versus daylight photodynamic therapy for actinic keratosis: A randomized and prospective study in China. , 2018, Photodiagnosis and photodynamic therapy.

[8]  L. Braathen.  Successful Daylight-PDT using a selfadhesive 5-aminolaevulinic acid patch , 2018, European Journal of Dermatology.

[9]  C. Morton,et al.  Daylight Photodynamic Therapy for Actinic Keratoses , 2018, American Journal of Clinical Dermatology.

[10]  A. Piccioni,et al.  Long-term efficacy data for daylight-PDT. , 2018, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia.

[11]  K. Peris,et al.  Defining the actinic keratosis field: a literature review and discussion , 2018, Journal of the European Academy of Dermatology and Venereology : JEADV.

[12]  A. Tanew,et al.  5‐aminolaevulinic acid patch‐photodynamic therapy in the treatment of actinic cheilitis , 2017, Photodermatology, photoimmunology & photomedicine.

[13]  Elizabeth Lazaridou,et al.  Epidemiological trends in skin cancer , 2017, Dermatology practical & conceptual.

[14]  J. McGregor,et al.  British Association of Dermatologists’ guidelines for the care of patients with actinic keratosis 2017 , 2017, The British journal of dermatology.

[15]  R. Szeimies.  A network meta‐analysis of the relative efficacy of treatments for actinic keratosis of the face or scalp in Europe , 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.

[16]  J. Paoli,et al.  Aminolevulinic acid and methyl aminolevulinate equally effective in topical photodynamic therapy for non‐melanoma skin cancers , 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.

[17]  A. Hauschild,et al.  Photodynamic therapy simplified: nonprepared, moderate‐grade actinic keratosis lesions respond equally well to 5‐aminolaevulinic acid patch photodynamic therapy as do mild lesions , 2015, British Journal of Dermatology.

[18]  S. Vegter,et al.  A Network Meta-Analysis of the Relative Efficacy of Treatments for Actinic Keratosis of the Face or Scalp in Europe , 2014, PloS one.

[19]  A. Sidoroff,et al.  European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications – actinic keratoses, Bowen’s disease, basal cell carcinoma , 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.

[20]  A. Hauschild,et al.  Long‐term follow‐up of photodynamic therapy with a self‐adhesive 5‐aminolaevulinic acid patch: 12 months data , 2010, The British journal of dermatology.

[21]  A. Hauschild,et al.  Optimization of photodynamic therapy with a novel self‐adhesive 5‐aminolaevulinic acid patch: results of two randomized controlled phase III studies , 2009, The British journal of dermatology.

[22]  A. Hauschild,et al.  Effective photodynamic therapy of actinic keratoses on the head and face with a novel, self‐adhesive 5‐aminolaevulinic acid patch , 2009, Experimental dermatology.

[23]  A. Moor,et al.  Fluorescence characteristics and pharmacokinetic properties of a novel self-adhesive 5-ALA patch for photodynamic therapy of actinic keratoses , 2008, Archives of Dermatological Research.

[24]  Geoffrey Lee,et al.  Self-adhesive thin films for topical delivery of 5-aminolevulinic acid. , 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.